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RNA-binding proteins (RBPs) are expressed broadly during both development and malignant transformation, yet
their mechanistic roles in epithelial homeostasis or as drivers of tumor initiation and progression are incompletely
understood. Here we describe a novel interplay between RBPs LIN28B and IMP1 in intestinal epithelial cells.
Ribosome profiling and RNA sequencing identified IMP1 as a principle node for gene expression regulation
downstream from LIN28B. In vitro and in vivo data demonstrate that epithelial IMP1 loss increases expression
of WNT target genes and enhances LIN28B-mediated intestinal tumorigenesis, which was reversed when we
overexpressed IMP1 independently in vivo. Furthermore, IMP1 loss in wild-type or LIN28B-overexpressing mice
enhances the regenerative response to irradiation. Together, our data provide new evidence for the opposing effects
of the LIN28B–IMP1 axis on post-transcriptional regulation of canonical WNT signaling, with implications in
intestinal homeostasis, regeneration and tumorigenesis.
[Keywords: LIN28B; IMP1; intestinal tumorigenesis; post-transcriptional regulation; ribosome profiling]
Supplemental material is available for this article.
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Post-transcriptional regulation of key growth and oncogenic pathways by RNA-binding proteins (RBPs) is an
emerging hallmark of cancer (Chatterji and Rustgi 2018).
Understanding the relative contribution and regulation
of gene transcription and translation to functional and
phenotypic outcomes is essential for generating effective
therapeutics. Given the large number of putative binding
targets and effector pathways downstream from RBPs,
their evaluation in vivo is critical to understanding the
prevailing effects of specific RBP:RNA target interactions
in variable biological contexts. Intestinal epithelial cells
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exhibit remarkable plasticity in their ability to rapidly
proliferate, differentiate, and undergo repair—processes
that are aberrantly regulated during tumorigenesis. While
the critical cellular pathways for epithelial injury repair
and tumor development are well studied, the relative
contribution of RBPs as key functional regulators of these
pathways are just beginning to be understood. A primary
role of RBPs is to bind to and regulate functionally interrelated target transcripts, forming functional units referred
to as “regulons” (Keene 2007; Morris et al. 2010; Chatterji
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and Rustgi 2018). The integration of transcriptional and
translational data has revealed that a significant number
of genes are highly regulated at the translational level, underscoring the potential significant contribution of RBPs
to numerous basic biological functions (Schafer et al.
2015). Pathways critical to epithelial homeostasis, such
as WNT signaling, are aberrantly activated in and can contribute to colorectal cancer (CRC) pathogenesis, resulting
in challenges for direct therapeutic targeting.
As a master regulator of the let-7 family of microRNAs
(miRs), LIN28B exerts its effects via suppression of let-7
processing and thus up-regulation of let-7 targets, including HMGA2 and IGF2BP1 (IMP1) (Boyerinas et al. 2008;
Piskounova et al. 2011). In addition, LIN28B acts as a pluripotency factor and promotes tumorigenesis in multiple
tissues (Viswanathan et al. 2009; Tu et al. 2015; Rahkonen
et al. 2016; Zhang et al. 2016). We demonstrated previously that LIN28B overexpression promotes migration and invasion in vitro and that CRC cells overexpressing LIN28B
exhibit smaller yet more metastatic tumors in subcutaneous xenograft mouse models. (King et al. 2011a,b). In addition, we and others have established LIN28B is a bone fide
oncogene in the intestinal epithelium (Madison et al.
2013; Tu et al. 2015). Furthermore, tumorigenesis was accelerated in mice with specific deletion of let-7c2/let-7b
as revealed by us, suggesting that the oncogenic effects
of LIN28B are predominantly via its regulation of let-7.
In support of this notion, deletion of a single allele of
the let-7 target Hmga2 repressed Lin28b-driven tumorigenesis (Madison et al. 2015). Other key let-7 targets upregulated in VillinLin28b mice include Igf2bp1, Igf2bp2,
E2f5, cyclinD1, and Acvr1c. Recognizing that LIN28B
functions as an oncogene in CRC and blocks processing
of pre/pri -let-7, we reasoned that let-7 mRNA targets
may be effectors of LIN28B-mediated oncogenic transformation. Specifically, we hypothesized that IMP1 may be a
critical effector of LIN28B’s actions.
IMP1 is a RBP with oncofetal functions that is expressed
minimally in adult tissues under homeostatic conditions.
We demonstrated previously in subcutaneous xenografts
that IMP1 overexpression in SW480 CRC cells exhibit increased tumor volume and elevated levels of its mRNAbinding target, CD44 (Hamilton et al. 2013). Conversely,
loss of both Imp1 alleles in stromal cells led to enhanced
tumor load in colitis-associated colon tumorigenesis
(Hamilton et al. 2015), indicating a tumor-suppressive
role for IMP1 in this nonepithelial compartment. Others
have reported diverse findings in other cancers; for example, overexpression of the IMP1 mouse homolog CRD-BP
in mammary epithelial cells resulted in mammary tumor
formation, with a subset of mice exhibiting metastasis
(Tessier et al. 2004). Conversely, studies in orthotopic
breast fat pad xenografts demonstrated that IMP1 overexpression suppressed the growth of MDA231 cell-derived
tumors and subsequent lung metastasis as well as an associated decrease in IMP1 mRNA-binding targets PTGS2,
GDF15, and IGF2 (Wang et al. 2016). Finally, ectopic Imp1
expression in the MMTV-PyMT breast cancer mouse
model significantly reduced metastatic tumors (Nwokafor et al. 2016). Based on these functional studies, we

conclude that IMP1 may exhibit oncogenic or tumorsuppressive functions in a context-dependent manner
that may vary from tissue to tissue and even within a
tissue (epithelial vs. mesenchymal). Furthermore, these
studies demonstrate that IMP1 may enhance or suppress
its mRNA-binding targets.
In the present study, we used the intestinal epithelium
as a prototypical model for understanding the tissue-specific roles of two key RBPs—LIN28B and IMP1—in the
context of fundamental homeostasis and tumorigenesis.
We performed novel and unbiased transcriptome and
translatome studies as a function of LIN28B expression
and found that IMP1 is the top regulator of differentially
expressed transcripts with LIN28B overexpression. We
next evaluated the in vivo consequences of LIN28B expression with and without IMP1 expression, elucidating
their functional relevance in intestinal homeostasis and
tumorigenesis with the finding that WNT signaling is pivotal. Taken together, our studies reveal a LIN28B–IMP1
axis governing a post-transcriptional regulon capable of
modulating intestinal epithelial cell growth and tumorigenesis via global control of the WNT pathway.
Results
IMP1 loss is a significant regulator of translation
in the context of LIN28B overexpression
To understand how LIN28B may modulate translation of
the transcriptome and how this is impacted by IMP1, we
used ribosome profiling to obtain a genome-wide snapshot
of translation in the context of LIN28B overexpression.
First, we evaluated SW480 CRC cells overexpressing
LIN28B (Supplemental Fig. 1A; King et al. 2011a,b). We
used translatome (Tebaldi et al. 2014) to identify putative
regulatory factors upstream of differentially translated
genes in LIN28B-overexpressing versus control cells.
This method computes a Fisher test P-value indicating
whether binding sites for each regulator are significantly
enriched in differentially expressed genes lists. This analysis allows the user to identify possible regulatory factors
responsible for the translational regulation of differentially
expressed genes in the experiment under consideration.
The list of genes regulated by each post-transcriptional
element was obtained from the Atlas of UTR Regulatory
Activity (AURA) database (Dassi et al. 2014). Through
this analysis, we identified IMP1 as a significant posttranscriptional regulator in LIN28B-overexpressing cells
(Fig. 1A).
Next, we analyzed differential gene expression between
LIN28B-overexpressing lines with and without CRISPR/
Cas9-mediated IMP1 deletion (Supplemental Fig. 1A) and
calculated log fold changes between ribosome-bound
RNAs (ribosome-protected fragments [RPFs]) and total
mRNA. A total of 1284 genes was regulated by IMP1 exclusively at the translational level, whereas 264 genes were
regulated only at the transcriptional level. Additionally,
458 genes were regulated via translational antagonism
(where genes exhibited increased mRNA levels but lower
translational efficiencies or vice versa) or translational
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Figure 1. IMP1 is a significant translational regulator downstream from LIN28B. (A) Radar map demonstrating the top post-transcriptional regulators of differentially expressed genes with LIN28B overexpression in SW480 cells as compared with control cells. A single
point on the radar map indicates −10 log P-value of enrichment of any post-transcriptional regulator. Differentially expressed genes at
each level were identified using the DEGseq, and the list of post-transcriptional regulators was obtained from the AURA database (see
the Materials and Methods). (B) Scatter plot of differential expression between LIN28B-overexpressing lines with and without IMP1 deletion.The log2 fold changes between ribosome-bound RNAs (ribosome-protected fragments [RPFs]) and total mRNA are plotted. The plot
indicates that IMP1 regulates both mRNA abundance and translation. (C) Scatter plot of genes with significant (in blue) differential translational efficiencies between LIN28B-overexpressing cells with and without IMP1 deletion. Translation efficiencies (TEs) of the transcripts were calculated as the ratio of reads of ribosome-protected fragments to the reads in total mRNA abundance. (D) Pathway
analysis using DAVID software of the differentially expressed genes from C to see what signaling/effector pathways are enriched with
IMP1 deletion (note the Wnt signaling pathway).

reinforcement (where translational changes amplified the
changes at the mRNA level) (Fig. 1B; Supplemental Table
11). These data demonstrate that IMP1 is a major translational regulator of target genes. Translational regulation
can occur through differential translation efficiencies
(TEs) of transcripts, which were calculated as the ratio of
RPF reads to total mRNA abundance. We observed several
transcripts with significantly different TE values between
cells overexpressing LIN28B with or without IMP1 deletion (Fig. 1C; Supplemental Table 9). Pathway enrichment
analysis for TE genes differentially expressed in LIN28B
cells with or without IMP1 deletion revealed a significant
representation of pathways linked to cancer, including the
WNT signaling pathway (Fig. 1D; Supplemental Tables 8,
10). Finally, gene set enrichment analysis (GSEA) of RNA
sequencing (RNA-seq) data from the same cells suggest
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that IMP1 deletion up-regulates WNT signaling at the
mRNA level as well (Supplemental Table 1), demonstrating IMP1 modulation of WNT at both transcript abundance/stability and TE levels in this context. We further
validated this in the SW480 cells overexpressing LIN28B
with and without IMP1 deletion (Supplemental Fig. 1C,
D). We saw a significant up-regulation of Wnt targets
with IMP1 deletion via quantiative PCR (qPCR) and upregulation of β-catenin protein levels via Western blot
in these cells. Finally, to validate up-regulation of Wnt
targets identified via RNA-seq, we used siRNA to knock
down IMP1 in Caco2 cells (Supplementary Fig. 4A,B) that
endogenously express LIN28B (Mizuno et al. 2018). We observed significant up-regulation of multiple WNT targets
with IMP1 knockdown, corroborating our findings in a
second, independent cell line (Supplemental Fig. 4A,B).
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In an attempt to elucidate whether direct binding may
correlate with TEs, we compared binding intensities of
IMP1 targets identified via previously published enhanced
UV cross-linking and immunoprecipitation (eCLIP) in human pluripotent stem cells (hPSCs) (Conway et al. 2016)
with differential TEs of these targets from the present
study (in human CRC cells). However, we found no correlation between binding intensities and TEs (Supplemental
Fig. 1B). In addition, a large number of targets identified
in eCLIP studies did not change significantly in our TE
data set and vice versa (Supplemental Table 2). While we
cannot exclude the possibility that differences between
mRNA-binding efficiencies and TEs may be due in part
to comparing hPSCs with CRC cells, these data nevertheless reinforce the concept that eCLIP-identified IMP1bound targets may not necessarily correlate with gene
expression changes (Conway et al. 2016).
IMP1 loss enhances LIN28B-mediated tumorigenesis
in vivo
Gene expression and ribosome profiling data suggest that
IMP1 loss causes dysregulation of several key signaling
pathways that are involved in cellular proliferation and
maintenance. To understand the phenotypic consequence
of these changes, we used LIN28B-overexpressing CRC
cells with and without IMP1 loss in subcutaneous xenograft experiments (Supplemental Fig. 2A). Consistent
with our prior published studies, LIN28B overexpression
caused a significant decrease in tumor volume as compared with controls, irrespective of IMP1 status (Supplemental Fig. 2B; King et al. 2011a). LIN28B-overexpressing
tumors exhibited a more differentiated phenotype as compared with controls, which had poorly differentiated tumors. This differentiation phenotype was reversed with
IMP1 loss in LIN28B-overexpressing cells (Supplemental
Fig. 2C), suggesting that IMP1 loss may promote an increase in stemness markers and/or down-regulate differentiation pathways in CRC cells. We also observed an
up-regulation of nuclear β-catenin staining with IMP1
loss and a significant increase in Wnt signature in these
tumors (Supplemental Fig. 2C,D).
To confirm that LIN28B expression in transformed cells
can promote differentiation, we evaluated LIN28B expression and differentiation status in human colon tumors in
colon cancer tissue microarrays (King et al. 2011a). We
found that the majority of LIN28B overexpressing tumors
was either moderately or well differentiated (Supplemental Fig. 2E). The mechanistic explanation for this is not
known; however, recent studies have demonstrated that,
in some CRC cell lines, overexpression of pluripotency
factors (OCT3/4, SOX2, and KLF4) can lead to tumors
with increased differentiation (Oshima et al. 2014). This
is in line with our finding, since LIN28B is also a pluripotency factor (Rahkonen et al. 2016; Zhang et al. 2016;
Tsanov et al. 2017), although this does not mean that
pluripotency and differentiation are necessarily linked in
this context.
We next evaluated transgenic mice with intestinal epithelial overexpression of Lin28b (Villin-Lin28b) and

intestinal epithelial-specific deletion of Imp1 (VillinCre;
Imp1 fl/fl) (Supplemental Fig. 2F; Hamilton et al. 2013;
Madison et al. 2013). Our prior work demonstrated de
novo intestinal tumor growth in Villin-Lin28b mice, confirming that Lin28b can act as an oncogene in the intestine (Madison et al. 2013). Imp1 expression is enhanced
significantly in Villin-Lin28b mice and completely
eliminated in the intestinal epithelium of Villin-Lin28b;
VillinCre;Imp1 fl/fl mice (Fig. 2A). We found that, at
12 mo of age, 18 out of 25 Villin-Lin28b mice (72%) had
at least one tumor, while 10 out of 12 (83.33%) VillinLin28b;VillinCre;Imp1fl/fl mice had tumors, the majority
of which had multiple lesions. Aged mice overexpressing
LIN28B exhibit a significant increase in the number
of proliferating cells (Fig. 2B,C) in normal tissue. VillinLin28b;VillinCre;Imp1 fl/fl mice exhibit a significant increase in intestinal tumor number per mouse compared
with Villin-Lin28b mice (Fig. 2D). We did not observe hyperplasia or tumor growth with Imp1 loss alone, evaluated
out to 12 mo of age. Histological grading revealed a higher
percentage of adenocarcinoma lesions in Villin-Lin28b;
VillinCre;Imp1 fl/fl mice compared with Villin-Lin28b
mice (Fig. 2E,F), demonstrating that Imp1 loss promotes
higher tumor number and grade in the context of Lin28b
overexpression.
Our prior studies demonstrated that Lin28b overexpression results in increased expression of other let-7 targets,
including Hmga2, Arid3a, Igf2bp2, and CycD1, as well as
enhanced expression of stem cell-related genes (Madison
et al. 2015). We evaluated isolated epithelia from aged
mice and found no significant change in Arid3a, Igf2bp2,
Hmga2, and CycD1 expression in Villin-Lin28b;VillinCre;
Imp1 fl/fl mice compared with Villin-Lin28b mice (Fig.
2G). We found a robust increase in stem cell and broader
crypt cell markers, including Prom1, Hopx, Bmi1, Lgr5,
and Olfm4 (van der Flier et al. 2009; Zhu et al. 2009; Takeda
et al. 2011; Tian et al. 2011; de Sousa e Melo et al. 2017),
suggesting an expansion of the stem cell compartment in
Villin-Lin28b;VillinCre;Imp1 fl/fl mice compared with
Villin-Lin28b mice (Fig. 2H). Consistent with an expansion of the crypt base stem cell compartment, we observed
an increase in WNT target gene expression with Imp1 loss
at both the mRNA and protein levels (Fig. 2I–K; Supplemental Fig. 3D). This effect was also observed ex vivo in
enteroids generated from isolated crypts, where VillinLin28b;VillinCre;Imp1 fl/fl enteroids exhibit increased
AXIN2 expression compared with wild-type or VillinLin28b mouse enteroids (Supplemental Fig. 2G). Together, these data support the hypothesis that IMP1 may modulate stem cell signature and canonical WNT target gene
expression in the intestine and that these effects persist
in isolated crypt enteroid cultures.
To understand these findings in the context of patients
with CRC, we evaluated The Cancer Genome Atlas
(TCGA) (Cline et al. 2013) for LIN28B and IMP1 expression
levels in colon and rectal adenocarcinoma (COADREAD)
patients. We found a positive correlation between the
two transcripts in patient tumors (Pearson’s coefficient =
0.266, P < 0.0001) (Supplemental Fig. 3A). However, tumor
stage-wise evaluation revealed higher IMP1 expression in
GENES & DEVELOPMENT
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all tumor stages, whereas LIN28B expression increased in
stage IV, supporting the concept that IMP1 expression is
regulated via additional mechanisms beyond LIN28B (Supplemental Fig. 3B).
A

B

D

E

Building on our observation that Imp1 loss up-regulates
stem cell and WNT target genes in the context of LIN28B
C

F

G

I

IMP1 contributes to intestinal epithelial regeneration

H

J

K

Figure 2. IMP1 loss enhances LIN28B-mediated tumorigenesis in vivo. Imp1 fl/fl (wild type), Villin-Cre;Imp1 fl/fl, Villin-Lin28b, and Villin-Cre;Villin-Lin28b;Imp1 fl/fl mice were aged up to 1 yr and then sacrificed to evaluate tumor growth. (A) Igf2bp1/Imp1 expression in the
epithelia isolated from the jejuna of 12-mo-old mice. n > 4 mice per genotype. (B) Representative immunofluorescence staining for EdU
incorporation in mouse intestinal epithelium. Bars, 500 µm. (C ) Quantification of EdU+ve cells using flow cytometry. n = 3 mice per genotype. (D) The number of intestinal tumors in mice with or without Imp1 in the context of Lin28b overexpression. n > 9 mice per genotype. (E) The percentage of tumors classified as adenocarcinomas by histological scoring. (F ) Representative hematoxylin and eosin (H&E)
staining of intestinal epithelia in aged mice. Mice lacking Lin28b overexpression exhibited normal intestinal morphology at 12 mo of age.
Mice with Lin28b overexpression exhibited tumor development that worsened with Imp1 loss. Bars, 500 µm. (G) Relative expression of
different let-7 targets in the intestinal epithelium via qPCR. n > 5 mice per genotype. (H) Relative expression of stem cell markers in the
intestinal epithelium via qPCR expressed as fold change with respect to Imp1 fl/fl mice. n > 5 mice per genotype. (I ) Relative expression of
Wnt target genes in the intestinal epithelium via qPCR expressed as fold change with respect to Imp1 fl/fl mice. n > 5 mice per genotype. (J)
Representative immunohistochemical staining for β-catenin in mouse intestinal epithelium (magnified in the inset). (K) Representative βcatenin protein levels in mouse intestinal crypts from the four genotypes. All data are expressed as mean ± SEM. (∗ ) P < 0.05; (∗∗ ) P < 0.01;
(∗∗∗ ) P < 0.001; (∗∗∗∗ ) P<0.0001 by ordinary one-way ANOVA test followed by Tukey’s multiple comparison test. The significance is shown
compared with control/wild-type samples unless indicated otherwise.
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overexpression, we sought to understand broader roles for
IMP1 in the context of intestinal homeostasis and repair
from injury. Radiation-mediated injury has been increasingly used to study stem cell function and regeneration
of the intestinal epithelium (Potten 2004; Zhou et al.
2013; Gregorieff et al. 2015). Imp1 expression is low in
the adult intestinal crypt but is increased in the regenerating epithelium following whole-body irradiation at both
the RNA and protein levels (Fig. 3A). We observed IMP1
protein expression specifically in regenerative foci 4 d following irradiation, a time point at which surviving stem
cells are undergoing rapid proliferation to replenish the
epithelium and restore barrier function (Fig. 3B). We
observed that Villin-Lin28b mice lose significantly
more weight at day 4 after irradiation as compared with
wild-type controls. This phenotype is reversed in VillinLin28b;VillinCre;Imp1 fl/fl mice, where Imp1 deletion
results in significantly less weight loss as compared

with Villin-Lin28b mice, returning to wild-type levels
(Fig. 3C). Furthermore, the number of regenerative crypts
at day 4 following radiation is significantly higher in
Villin-Lin28b;VillinCre;Imp1 fl/fl mice compared with
Villin-Lin28b mice (Fig. 3D). Villin-Lin28b;VillinCre;
Imp1 fl/fl mice also display decreased H2AX foci (Zhou
et al. 2015) as compared with Villin-Lin28b mice, thus indicating less DNA damage at day 4 after radiation (Supplemental Fig. 3C). Thus, the beneficial effect may be due to
both enhanced WNT signaling and WNT-independent
protective effects.
Evaluating IMP1 separately from its function downstream from LIN28B, we observed that VillinCre;Imp1 fl/fl
mice exhibit less weight loss following irradiation compared with control Imp1 fl/fl mice (Fig. 3E) and that the
number of regenerative crypt foci is increased in VillinCre;Imp1 fl/fl mice (Fig. 3F,G). Crypt regeneration in
VillinCre;Imp1 fl/fl mice was evaluated further by plating

Figure 3. IMP1 regulates intestinal epithelial regeneration following irradiation. Mice were evaluated for Imp1
expression in nonirradiated conditions and 4 d after 12
Gy of whole-body irradiation. (A) qRT–PCR and representative Western blot for Imp1 in isolated crypts
from these mice. (∗ ) P < 0.05 versus nonirradiated. n =
3–4 mice per genotype. (B) Representative immunohistochemical staining showing Imp1 increase in wildtype (Imp1fl/fl) mice following radiation. VillinCre;
Imp1 fl/fl mice were used as controls. Bars, 500 µm.
mice
lost
(C )
Villin-Lin28b;Villin-Cre;Imp1 fl/fl
C
D
E
significantly less weight at sacrifice following irradiation than Villin-Lin28b mice (22.23% ± 0.9905% mean
weight loss in Villin-Cre;Villin-Lin28b;Imp1 fl/fl mice
[n = 3] vs. 26.68% ± 0.4076% in Villin-Lin28b [n = 5]).
The weight loss in Villin-Lin28b mice was significantly
higher than in controls (22.24% ± 0.2556% mean weight
loss). (D) Analysis of Ki67+ cells revealed a significant increase in Ki67+ regenerative crypt foci in VillinCre Villin-Lin28b;Imp1 fl/fl mice at 4 d following irradiation. n
= 3–4 mice per genotype; n = 20–30 high-power fields
(HPFs) per mouse. Representative immunohistochemical staining for Ki67+ foci in the mouse intestinal epithelium is shown. Bars, 500 µm. (E) VillinCre;Imp1 fl/fl mice
lost significantly less weight at sacrifice following irraF
G
H
diation than controls (18.83% ± 0.98% in VillinCre;
Imp1 fl/fl mice vs. 23.34% ± 0.56% mean weight loss in
controls). n = 14 Imp1 fl/fl mice; n = 12 VillinCre;Imp1 fl/
fl
mice. (F ) Analysis of Ki67+ cells revealed a robust increase in Ki67+ regenerative crypt foci in VillinCre;
I
Imp1 fl/fl mice at 4 d following irradiation. n = 4 mice
per genotype; n = 20–30 HPFs per mouse. (G) Representative immunohistochemical staining for Ki67+ foci in
the mouse intestinal epithelium. Bars, 500 µm. (H) Representative pictures of the enterosphere and enteroid
with buds. Enhanced growth of post-irradiation enteroids from VillinCre;Imp1 fl/fl mice. Regenerative crypt
units were plated in enteroid culture on the day of sacrifice to evaluate ex vivo survival and growth. (I) Evaluation of enterosphere growth 1 d following plating and enteroid growth 4 d after plating revealed a significant increase in VillinCre;Imp1 fl/fl
compared with Imp1 fl/fl. All data are expressed as mean ± SEM. (∗ ) P < 0.05; (∗∗ ) P < 0.01; (∗∗∗ ) P < 0.001; (∗∗∗∗ ) P < 0.0001 by ordinary one-way
ANOVA test followed by Tukey’s multiple comparison test. The significance is shown compared with control/wild-type samples unless
indicated otherwise.
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post-irradiated crypts in three-dimensional (3D) enteroid
culture (Fig. 3H; Fuller et al. 2012). Crypt enteroids from
untreated Imp1 fl/fl and VillinCre;Imp1 fl/fl mice establish
and grow at similar rates under homeostasis (Supplemental
Fig. 4C); however, post-irradiated crypts from VillinCre;
Imp1 fl/fl mice exhibit a significant increase in enterosphere formation as well as growth into enteroids 4 d after
plating (Fig. 3I).
Our data demonstrating that Imp1 deletion enhances
Lin28b-mediated tumorigenesis and regeneration in both
wild-type and Villin-Lin28b mice may be counterintuitive to current views of IMP1 function. We therefore
generated mice in which Imp1 is overexpressed in the intestinal epithelium (VillinCre Imp1 OE) (Supplemental
Fig. 4D,E). We analyzed aged mice (10–12 mo) and found
no tumors (Fig. 4A) or any significant difference in intestinal morphology in VillinCre Imp1 OE or Villin-Lin28b;
VillinCre Imp1 OE mice compared with wild-type control
mice (Fig. 4B). We did not observe a significant difference
in Paneth, goblet, or enteroendocrine cell numbers (Supplemental Fig. 5A). Intriguingly, irradiated VillinCre;
Imp1 OE mice did not exhibit significant differences in
weight loss compared with control mice at day 4, although
there was a trend for increased weight loss in VillinCre
Imp1 OE mice (Supplemental Fig. 5B). Taken together,
these data confirm in an independent manner that IMP1
overexpression by itself is insufficient to initiate tumors.
We observed up-regulation of Wnt targets in Lin28b;
VillinCre;Imp1 fl/fl mice. To evaluate whether VillinCre;
Imp1 OE mice exhibit opposing effects, we analyzed gene
expression in Villin-Lin28b;VillinCre;Imp1 OE mice.
Analysis of 10- to 12-mo-old mice revealed a decrease in

A

B

C
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Wnt target gene expression in Villin-Lin28b;VillinCre;
Imp1 OE mice compared with Villin-Lin28b mice. This
supports the hypothesis that Imp1 loss may serve as a
“switch” for canonical Wnt target gene regulation in
the context of Lin28b overexpression (Fig. 4C). Finally,
analysis of aged Villin-Lin28b;VillinCre;Imp1 OE mice
revealed a suppression of tumor incidence compared
with Villin-Lin28b mice (Fig. 4A). In summary, the
functional effects observed in mice with Imp1 loss or
overexpression provide evidence that Imp1 acts as a suppressor of the epithelium’s proliferative response under
nontransformed conditions, due in part to regulation of
Wnt signaling. In this regard, high IMP1 in CRC patients
is likely an “effect” rather than a “cause” of tumor
initiation.
IMP1 plays a functional role in reserve intestinal
stem cells
We performed RNA-seq followed by GSEA on isolated
crypts from Imp1 fl/fl and VillinCre;Imp1 fl/fl mice to
evaluate baseline changes in gene expression with Imp1
loss. Similar to Villin-Lin28b;VillinCre;Imp1 fl/fl mice,
crypt gene expression analysis in VillinCre;Imp1 fl/fl
mice revealed an increase in intestinal stem cell and
Wnt target gene expression (Fig. 5A; Supplemental Fig.
6A). GSEA revealed enrichment of gene targets involved
in proliferation, regeneration, and Wnt signaling in
VillinCre;Imp1 fl/fl mice compared with control mice (Pvalue < 0.001; false discovery rate [FDR] < 0.001) (Supplemental Table 6). We validated up-regulation of Wnt
targets identified via RNA-seq using siRNA to knock
Figure 4. IMP1 overexpression does not initiate tumors
in vivo. (A) The VillinCre;Imp1 OE mice did not exhibit
tumor formation between 10 and 12 mo of age. (B) Representative H&E and Ki67 staining of intestinal epithelia
in aged (10–12 mo) mice. Mice overexpressing IMP1 exhibited normal intestinal morphology and did not show
a tumor phenotype. Bars, 500 µm. (C ) Relative expression of Wnt target genes in the intestinal epithelium
via qPCR expressed as fold change with respect to
wild-type control mice at 10–12 mo of age. n = >4 mice
per genotype. All data are expressed as mean ± SEM. (∗ )
P < 0.05; (∗∗ ) P < 0.01; (∗∗∗ ) P < 0.001 by ordinary oneway ANOVA test followed by Tukey’s multiple comparison test.
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down IMP1 in Caco2 cells (Supplemental Fig. 4A,B), which
endogenously express LIN28B (Mizuno et al. 2018). We
observed significant up-regulation of multiple WNT targets with IMP1 knockdown in these cells.
VillinCre;Imp1 fl/fl mice lack Imp1 in all intestinal epithelial cells, including stem, progenitor, and differentiated cells. Based on the up-regulation of stem cell-related
and Wnt target genes in VillinCre;Imp1 fl/fl mice, we
reasoned that Imp1 may exhibit a functional role within
the intestinal crypt compartment. To confirm Imp1 gene
expression in small intestine crypt cells, we used Sox9EGFP reporter mice in which subpopulations of intestinal
epithelial cells are fractionated by their relative EGFP expression using fluorescent-activated cell sorting (FACS).
Sox9-EGFP-negative, Sox9-EGFP sublow, Sox9-EGFP low,
and Sox9-EGFP high segregate into populations of
differentiated cells, progenitor/transit-amplifying cells,
active crypt base stem cells, and a mixed population of reserve stem cells/secretory progenitors/enteroendocrine
cells, respectively (Formeister et al. 2009; Gracz et al.
2010; Van Landeghem et al. 2012; Roche et al. 2015).
Subpopulations were validated previously with gene
expression and functional assays. In Sox9-EGFP mice,
Imp1 expression is significantly higher in Sox9-EGFP
low and Sox9-EGFP high cells as compared with differentiated lineages (Sox9-EGFP-negative cells) (Fig. 5B). Fur-

Figure 5. IMP1 plays a functional role in reserve
intestinal stem cells. (A) qRT–PCR for stem cell
markers and Wnt target genes in isolated crypts
from VillinCre;Imp1fl/fl mice compared with
Impfl/fl mice. n = 3–4 mice per genotype. (B)
qPCR in Sox9-EGFP reporter mice, where epithelial cell populations are subclassified viafluorescent-activated cell sorting (FACS) into Sox9EGFP0-negative, Sox9-EGFP0 sublow, Sox9EGFP0 low, and Sox9-EGFP0 high cells. Imp1 is
expressed at low levels in all represented cell types
except Sox9-EGFP-negative cells (white bars).
Imp1 expression is significantly higher in Sox9EGFP low and Sox9-EGFP high cells, which encompass intestinal stem cells. n = 5 animals per
group. (C) HopxCreERT2;Imp1 fl/fl mice lost significantly less weight at sacrifice following irradiation than controls (18.8% ± 1.951% mean weight
loss in HopxCreERT2;Imp1 fl/fl mice vs. 23.92% ±
1.015% in controls). n = 8 HopxCreERT2;Imp1fl/fl;
n = 12 control mice. (D) Analysis of Ki67+ cells revealed there was a robust increase in Ki67+ regenerative crypt foci at 4 d following irradiation in
HopxCreERT2;Imp1 fl/fl mice compared with control mice. n = 4 mice per genotype; n = 20–30 HPFs
per animal. Bars, 500 µm. (E) Representative immunohistochemical staining for Ki67+ foci in the
mouse intestinal epithelium quantified in D.
(F ) qPCR for Imp1 expression in Lgr5+ and Paneth
(CD24/cKit/SSC high) cells sorted from Lgr5eGFP-IRES-CreERT2 mouse crypts. All data are
expressed as mean ± SEM. (∗ ) P < 0.05; (∗∗ ) P <
0.01; (∗∗∗ ) P < 0.001; (∗∗∗∗ ) P < 0.0001 by unpaired
t-test.

thermore, Imp1 expression is up-regulated in all cell
populations following whole-body irradiation, with a
significant increase in Sox9-EGFP high cells relative to
other cells types (Supplemental Fig. 6B).
To determine whether the protective effect of Imp1
loss persists in a more restricted epithelial population,
we crossed Imp1 fl/fl mice to mice harboring the HopxCreERT2 knock-in allele (Li et al. 2016), which is
expressed specifically in WntNegative quiescent reserve
stem cells (Takeda et al. 2011; Li et al. 2014; Yousefi
et al. 2016). Similar to VillinCre;Imp1 fl/fl mice, we found
that HopxCreERT2;Imp1 fl/fl mice exhibit less weight
loss following irradiation compared with controls (Fig.
5C) and an increase in regenerative crypt foci, consistent
with enhanced recovery following injury (Fig. 5D,E). To
verify that Imp1 is enriched in the crypts using a second
model, we used Lgr5-eGFP-IRES-CreERT2 mice. We
performed gene expression analysis for Imp1 in Lgr5 +
and Paneth (CD24/cKit/SSC high) cells sorted from
Lgr5-eGFP-IRES-CreERT2 mouse crypts. We observed
that Imp1 is enriched in both Lgr5 + and Paneth cells compared with unsorted crypts (Fig. 5F). Taken together, these
data support a role for IMP1 induction to negatively regulate WNT signaling during homeostasis (putatively in
crypt cells with an inactive canonical Wnt signaling pathway during homeostasis).
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In aggregate, we propose a model in which LIN28B
overexpression promotes increased proliferation and tumorigenesis and enhances IMP1 expression, which may
then feed back and suppress these pathways during
homeostasis (Fig. 6). This mechanism is reinforced by
data in Villin-Lin28b;VillinCre;Imp1 fl/fl mice (where
Imp1 loss enhances Lin28b-mediaated tumorigenesis
and up-regulates Wnt signaling) and Villin-Lin28b;VillinCre;Imp1 OE mice (where high Imp1 expression reduces
Lin28b-mediated tumorigenesis).

Discussion
In the present study, we used ribosome profiling to demonstrate that IMP1 acts as a pivotal regulator downstream
from LIN28B and that IMP1 deletion promotes changes
to both mRNA levels and TEs. Globally, there is partial
overlap in genes that are regulated at the mRNA and
translation levels, suggesting that IMP1 may regulate
both homeostatic transcript abundance and TE for a
subset of target transcripts. In addition, we found no correlation between the binding efficiencies of targets from
eCLIP studies (Conway et al. 2016) and the changes in
their TEs through ribosome profiling. This notion is
supported by recent studies comparing eCLIP-identified
IMP1-bound targets with gene expression changes in
IMP1-depleted cells, where there was no significant correlation between binding and trends in gene expression
changes (Conway et al. 2016). Additionally, there are targets that are not revealed in the eCLIP studies but are
found to be differentially regulated by ribosome profiling,
highlighting the tissue-specific as well as potentially
direct/indirect roles of IMP1 on gene expression. Our
data support the significance of evaluating both the transcriptome and translatome simultaneously to understand
RBP function and the notion that evaluating translational
reinforcement, antagonism, and buffering may uncover
additional roles for RBPs to refine the functional outcome
of a gene or pathway.
LIN28B is a critical pluripotency factor and is engaged
in diverse cancer types, including CRC (Rahkonen et al.
2016; Zhang et al. 2016; Tsanov et al. 2017). LIN28B
acts to a major extent through the post-transcriptional

down-regulation of the let-7 miR family. This enables
the induction of let-7 mRNA targets, which are normally
suppressed. In most contexts, this should lead to enhanced proliferation, growth, and, presumably, a pathway
toward transformation. While the let-7 mRNA targets
are many (e.g., CyclinD1, HMGA2, IMP1, and IMP2), it
remains elusive how precisely LIN28B exerts its actions
through the let-7 mRNA targets. Here, we found that
IMP1 regulates the TEs of genes downstream from
LIN28B, with one node through Wnt signaling pathway
components. Pathway analyses highlight several pathways involved in cancer (affecting proliferation, migration,
differentiation, and apoptosis), including WNT signaling,
that are significantly enriched with Imp1 deletion and
concurrent Lin28b expression. These genes are regulated
by changes in translational efficiencies by differential
binding of ribosomes on the transcripts—a finding that
expands substantially our knowledge about IMP1 and
WNT signaling, building significantly on a previous study
showing that β-catenin induces IMP1 transcription and
that IMP1 stabilizes β-catenin mRNA (Gu et al. 2008).
We demonstrate that Imp1 loss in Lin28b transgenic
mice promotes a robust increase in high-grade tumors exhibiting phenotypically less differentiation as well as a
more invasive phenotype, up-regulation of stem/progenitor cell genes, and enhanced nuclear β-catenin, suggesting
that Imp1 loss may promote expansion of the intestinal
stem cell compartment. This is in contrast to data in neural stem cells, where Imp1 deletion promoted differentiation (Nishino et al. 2013). Similarly, the finding that Imp1
loss promotes tumorigenesis in the intestinal epithelium
is in contrast to prior studies suggesting that IMP1 may
act as an oncogene in different tissues (Tessier et al.
2004; Kobel et al. 2007; Mayr and Bartel 2009; Hamilton
et al. 2013; Gutschner et al. 2014). However, more recent
studies have identified tumor-suppressive roles of IMP1 as
well (Hamilton et al. 2015; Wang et al. 2016). These divergences likely depend on numerous factors, including age,
the compartment in which Imp1 is expressed (for example, epithelial vs. mesenchymal), the specific tissue type
(intestinal, breast, brain, etc.), and whether Imp1 loss is
acting alone or in concert with known oncogenes. IMP1
stabilizes β-catenin mRNA in breast cancer cells (Gu
et al. 2008) and is activated by it in turn in a feedback

Figure 6. IMP1 is the principal node for post-transcriptional regulation downstream from LIN28B.
We propose a model in which IMP1 plays an important regulatory role downstream from LIN28B. Both
LIN28B overexpression and whole-body irradiation
enhance IMP1 expression in the intestinal epithelium. Deletion of IMP1 causes a significant increase
in LIN28B-mediated tumorigenesis, likely due in
part to observed increases in Wnt signaling and, potentially, stem cell signature. Furthermore, IMP1
loss (specifically in Hopx+ stem cells) causes increased regeneration following radiation injury. Taken together, these data suggest IMP1 as a regulator of
intestinal epithelial homeostasis downstream from
both LIN28B and radiation.
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mechanism (Gu et al. 2009). In other studies, IMP1 was
shown to bind and stabilize β-TRCP1, a β-catenin antagonist (Elcheva et al. 2009) . Hence, we used unbiased approaches (RNA-seq and ribosome profiling/sequencing)
to evaluate global changes in pathways with IMP1 loss
and then used in vivo mouse models to understand the
net effects on WNT pathway signaling. However, our
data do not necessarily exclude a role for IMP1 in tumor
progression, where it may exhibit different roles based
on target transcript abundance.
Although LIN28B has been reported to range from 30%
to 75% of CRC tumors (Piskounova et al. 2011; Tu et al.
2015), IMP1 is overexpressed in up to 80% of CRCs
(King et al. 2011a; Mongroo et al. 2011). This suggests
that the LIN28B–Let7–IMP1 axis may function under
certain scenarios, but other LIN28B-independent factors
yet to be identified in CRC may still regulate IMP1 expression. This is supported by our analysis using TCGA,
where LIN28B and IMP1 expression do not positively
correlate at all stages of colon cancer. Importantly, our
finding that VillinCre;Imp1 OE mice do not exhibit spontaneous tumor initiation suggests that IMP1 overexpression
is itself insufficient to drive tumor initiation. To that
end, it is possible that IMP1 overexpression may serve as
a “brake” or “checkpoint” to the oncogenic effects of
LIN28B. The “checkpoint” regulation may be achieved
through a variety of mechanisms ascribed to IMP1, such
as sequestration of transcripts in IMP1-containing ribonucleoprotein (RNP) granules (to avoid mRNA degradation
and/or release the transcripts for translation at critical
time points) (Jonson et al. 2007; Weidensdorfer et al.
2009), reduction of miR-mediated silencing of mRNA
transcripts (Elcheva et al. 2009; Nishino et al. 2013; Busch
et al. 2016; Degrauwe et al. 2016; for review, see van Kouwenhove et al. 2011), or displacement of miR-containing
RISCs (Elcheva et al. 2009). IMP1 may also enhance the
expression of LIN28B by shielding LIN28B mRNA from
regulation by let-7 in vitro (Busch et al. 2016). Additionally, Lin28b and Drosophila Imp1 (dImp1) cooperate in mitotic activity and oncogenesis (Narbonne-Reveau et al.
2016). Furthermore, LIN28B and IMP1 may cooperate
to augment cellular bioenergetics and, in the case of
LIN28B, cell metabolism (Tu et al. 2015). Nevertheless,
the LIN28B–IMP1 post-transcriptional regulon may be
viewed potentially as a node in CRCs that feature APC
loss/β-catenin activation/Wnt signaling activation.
Targeting key pathways in CRC remains challenging, as
so many of these pathways are important for normal epithelial homeostasis. The targeting of RBPs can be refined
to interrupt specific RBP:RNA transcript interactions.
LIN28B and IMP1 exhibit low expression in most adult
tissues, suggesting that targeting them may have few
deleterious effects. Inhibitors for LIN28B would prevent
aberrant blockade of tumor suppressor let-7, whereas
a specific IMP1 inhibitor would require targeting of tumor-promoting interactions while sparing tumor suppressor functions. For example, a novel IMP1 inhibitor that
targets c-Myc specifically has demonstrable effects on
melanoma and ovarian cell proliferation; however, studies
have been limited to in vitro assays thus far (Mahapatra

et al. 2014, 2017). In summary, our findings highlight
the LIN28B/IMP1 signaling axis as a key regulon for
normal homeostasis, radiation-mediated injury, and tumorigenesis in the intestinal epithelium, providing mechanistic insights into the basic biology of RBPs as well as
underscoring the importance of understanding post-transcriptional regulation of principle oncogenic pathways
in vivo.

Materials and methods
Cell lines and cell culture

CRC cell lines were obtained from American Type Culture Collection and authenticated by short tandem repeat (STR). Stable
LIN28B expression in SW480 and LoVo cells was achieved using
MSCV-PIG-LIN28B and empty vector control plasmids (gifts
from Dr. Joshua Mendell) using the protocol described previously
(King et al. 2011b). IMP1 was knocked out by cotransfecting cells
with IMP-1 CRISPR/Cas9 knockout plasmid (h) (Santa Cruz
Biotechnology, sc-401703) and IMP-1 HDR plasmid (h) (Santa
Cruz Biotechnology, sc-401703 HDR) followed by sorting and
clonal expansion of RFP+ve cells. The knockout was verified by
Western blotting for IMP1. IMP1 was knocked down in CaCo2
cells by siRNA transfection using Lipofectamine RNAiMax as
per the manufacturer’s guidelines. Silencer select negative control #1 siRNA from Thermo Fisher was used as a negative control.
qRT–PCR was used to validate knockdown. Cell lines were cultured in DMEM (Thermo Fisher Scientific) supplemented with
10% FBS (GE Healthcare Life Sciences) and 1% penicillin–streptomycin (Thermo Fisher Scientific) in a 37°C incubator with 5%
CO2 under puromycin selection. Cells are tested for mycoplasma
at least every 2 mo in the laboratory.

Animal models

VillinCre;Vil-Lin28b;Imp1 fl/fl mice were obtained by mating VilLin28b Med and VillinCre;Imp1 fl/fl mice that have been described
previously (Hamilton et al. 2013; Madison et al. 2013) and were
maintained via backcrosses to C57BL/6J. Imp1 fl/fl mice were considered wild type and expressed LIN28B and IMP1 insignificantly
differently from wild-type mice. Lgr5-EGFP-IRES-creERT2 mice
were purchased from Jackson Laboratories. The HopxCreERT2;
Imp1 fl/fl mice were generated by crossing Imp1 fl/fl mice with
tamoxifen-inducible Hopx-CreERT2 (JAX strain 017606) mice
that were generated at the University of Pennsylvania in the
laboratory of J. Epstein (Philadelphia, PA) and have been characterized previously (Yousefi et al. 2016). Sox9-EGFP mice were
maintained as described previously (Van Landeghem et al.
2012). Cyagen was used to generate Imp1OE mice. Briefly, the
knock-in construct was generated by amplification of mouse
genomic fragments from a BAC clone using high-fidelity DNA
polymerase. The targeting vector was assembled to include
Flag-tagged Imp1 (Igf2bp1) cDNA targeted to the Rosa locus
downstream from the EF1α promoter and a polyA sequence
flanked by loxP sites (Supplemental Fig. 4B). In addition, we
included an IRES;tdTomato;SV40EpolyA following the Imp1
cDNA. We crossed these mice with Villin-Cre mice in order to
specifically overexpress Imp1 in intestinal epithelial cells. All
experimental analyses were performed on three or more individual mice (male or female mice at 12-mo of age for tumor studies
and 8- to 12-wk-old mice for irradiation studies). Controls
and experimental groups were either sex-matched littermates
or age-matched sex-matched nonlittermates. To ablate Imp1 in
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HopxCreERT2;Imp1 fl/fl mice, tamoxifen (Sigma-Aldrich) was
dissolved in peanut oil at 10 mg/mL, and 200 µg of tamoxifen
per gram of body weight was injected intraperitoneally for each
dose. Two doses were administered 24 h apart before the irradiation experiments. Whole-body γ-irradiation (12 Gy) was administered to at least three mice in each group. For irradiation
experiments using VillinCre;Imp fl/fl mice, animals were given
a whole-body single dose of 12 Gy using the Gammacell 40
cesium 137 irradiation unit. Irradiation of Sox9-EGFP mice was
performed as described previously (Van Landeghem et al. 2012).
Body weights were recorded daily, and mice were euthanized
before losing a maximum of 25% total body weight at day 4 after
irradiation. All mouse protocols were approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania under protocol 804607.

Ribosome profiling

Ribosome profiling libraries from three pooled cell culture plates
were prepared using a standard protocol (McGlincy and Ingolia
2017) with minor modifications. Separate 5′ and 3′ linkers were
ligated to the RNA fragment instead of 3′ linker followed by
circularization (Subtelny et al. 2014). 5′ linkers contained four
random nucleotide unique molecular identifiers (UMIs), similar
to a 5-nucleotide (nt) UMI in 3′ linkers. During size selection,
we restricted the footprint lengths to 18–34 nt. Matched RNAseq libraries were prepared using RNA that was randomly fragmentated by incubating for 15 min at 95°C in 1 mM EDTA,
6 mM Na2CO3, and 44 mM NaHCO3 (pH 9.3). RNA-seq fragments were restricted to 18–50 nt. Ribosomal RNA (rRNA)
were removed from pooled RNA-seq and footprinting samples using RiboZero (Epicenter, MRZH116). cDNA for the pooled library
were PCR-amplified for 15 cycles.

Ribosome profiling data processing and analysis

RNA-seq and footprinting reads were mapped to the human transcriptome using the riboviz pipeline (Carja et al. 2017). Sequencing adapters were trimmed from reads using Cutadapt 1.10
(Martin 2011) using parameters ‐‐trim-n -O 1 ‐‐minimum-length
5. The reads from different samples were separated based on the
barcodes in their 3′ linkers using fastx_barcode_splitter (FASTX
toolkit, Hannon laboratory) with one mismatch allowed at
most. UMIs and barcodes were removed from reads in each sample using Cutadapt (‐‐trim-n -m 10 -u 4 -u -10). Trimmed reads
that aligned to human/mouse rRNA were removed using Bowtie
version 1.1.2 (Langmead et al. 2009). Remaining reads were
mapped to a set of 19,192 principal transcripts for each gene in
the APPRIS database (Rodriguez et al. 2013) using HISAT2 version 2.1.0 (Kim et al. 2015). Only reads that mapped uniquely
were used for all downstream analyses. For genes with multiple
principal transcripts, the first one in the list was chosen. Codes
for selecting these transcripts were obtained from the riboviz
package (https://github.com/shahpr/riboviz) (Carja and Plotkin
2017). For the radar map, the list of post-transcriptional regulators
was obtained from the AURA database (Dassi et al. 2014), and the
plot was generated using modified functions of the translatome
(Tebaldi et al. 2014) package in R. The translatome package was
modified to restrict the list of post-transcriptional regulators to
the regulators of the 19,192 genes used for mapping reads. All
analyses of ribosome profiling data sets were performed in
R. We restricted analyses to genes with at least one data set
(RNA-seq or footprinting across conditions) with 64 mapped
reads, and genes with 0 read counts in any data set were ignored
unless the mean read counts across all eight data sets were >64.
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Differentially expressed genes were identified using the DEGseq
package (Wang et al. 2010) using a false discovery rate (FDR)
cutoff of 0.001. Gene ontology (GO) enrichment analyses and
identification of post-transcriptional regulators of differentially
expressed genes at the transcriptome and translatome levels
were performed using the translatome package.

RNA-seq

RNA was isolated from freshly isolated mouse intestine crypts
and cell lines using the GeneJET RNA purification kit according
to the manufacturer’s instructions, with DNase treatment. The
cDNA libraries were then generated using the Illumina TruSeq
stranded mRNA library preparation kit with Ribo Zero treatment
(RS-122-2201). The cDNA was sequenced using HiSeq 50 cycle
single-read sequencing version 4 by the High-Throughput Genomics Core at the Huntsman Cancer Institute, University of Utah,
for a fee. All sequencing reads were first trimmed to remove 3′
sequencing adapters and aligned to the hg19 human genome
with STAR using the default parameters (Dobin et al. 2013).
Read counts for each gene were measured using HTSeq run in
“intersection-strict” mode (Anders et al. 2015), and differential
expression analysis was performed using DESeq2 (Love et al.
2014). Taking all differentially expressed genes with an FDR
of <0.05, GO analysis was performed using DAVID (Huang da
et al. 2009a,b). Genotypes were run in triplicates, and DESeq2
analysis was performed on them. GO analysis was performed
on the differentially expressed genes. GSEA was performed according to previously established guidelines (Subramanian et al.
2005).

TCGA analyses

Publicly available gene expression data from TCGA were downloaded from the Genomic Data Commons (GDC) data portal,
and graphs were generated using Graphpad Prism. Tumor
type and stage data were acquired from the University of California at Santa Cruz (UCSC) Xena (http://xena.ucsc.edu). Pooled
COADREAD data contained 433 samples in different tumor
stages. For staging, high expression and low expression groups
were determined by cutoff at the 75th percentile.
Correlation of expression was determined via χ2 analysis, and
95% confidence interval was calculated for confirmation of statistical significance in Graphpad Prism.

Tumor tissue microarray analysis

A tumor tissue microarray comprised of a uniform cohort of 228
(133 male and 95 female) patients with colon carcinoma (88
in stage 2 and 140 in stage 3) diagnosed between November
1993 and October 2006 was used. Rectal tumors were excluded
(King et al. 2011a). LIN28B staining intensity was scored by a
pathologist (A.J.K.-S.); 1 was used to signify low Lin28b intensity,
2 was used to signify intermediate intensity, and 3 was used to
signify high intensity. We used the high-expressing samples and
analyzed the differentiation status by the three-tier tumor grading system recommended by the American Joint Commission
(Edge and Compton 2010).

Enteroid culture and analyses

The proximal jejunum (6 cm) was flushed with cold PBS and cut
lengthwise to expose the luminal surface. Tissue was placed in
calcium–magnesium-free Hank’s buffered salt solution (CMFHBSS) with 1 mM N-acetyl cysteine, vortexed briefly, and placed
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on ice. The tissue was then transferred to CMF-HBSS containing
10 mM EDTA and 1 mM NAC and incubated for 45 min at 4°C
with end-to-end rotation. Epithelial cells were then mechanically
dissociated by vortexing for 30 sec following a 30-sec rest on ice;
this was repeated a total of four times. The villi were removed by
filtering over a 70-µm filter. Crypts were pelleted at 100g for
4 min and resuspended in Basal+ medium (advanced DMEM/
F12 containing 2 mM, 10 mM HEPES, 1× penicillin/streptomycin, 5 µM CHIR99021, 1 mM NAC, 1× N2 supplement, 1× B27
supplement for quantification). Crypts were defined as small Ushaped structures (or partial U-shaped structures for irradiated
mice). Crypts were plated in four wells of a 48-well plate per
mouse at a density of 150 crypts per well in an 80/20 mixture of
Matrigel matrix and Basal+ medium also containing 50 ng/mL
mouse epidermal growth factor and 2.5% Noggin/R-spondin
conditioned medium (Sato et al. 2009). After Matrigel solidified,
crypt-containing patties were overlaid with ENR medium. The
number of surviving crypt spheres (enteroids) was counted on
days 1–4 following plating to determine enteroid plating efficiency. On day 4 after plating, the number of surviving enteroids was
scored. All counting was performed at 10× magnification using
the Olympus IX81 inverted microscope. A crypt sphere was defined as a 3D sphere or oval shape surrounding a lumen (i.e.,
enterosphere). A “budded” enteroid was defined as a 3D structure
with one or more de novo projections of any length representing
crypts emerging from the spheroid body.

qRT–PCR

Small intestine crypt RNA was isolated using the GeneJet RNA
purification kit. Equal amounts of total RNA were reverse-transcribed using the TaqMan RT reagent kit, and the resulting
cDNA was used with Power SYBR Green PCR master mix
and validated primer sets listed in Supplemental Table 3. Non-reverse-transcribed samples were used as negative controls, and
gene expression was calculated using the R = 2(−ΔΔCt) method,
where changes in Ct values for the genes of interest were normalized to housekeeping genes Tbp, Rsp6, or Gapdh. Gene expression data are expressed as fold change versus mean values for
wild-type or untreated controls. All experiments were replicated
in at least three independent experiments with technical replicates (duplicates) in each experiment. For analyses of Sox9EGFP mice, FACS isolation of Sox9-EGFP cell populations
was performed as described previously (Van Landeghem et al.
2012). Total RNA from all Sox9-EGFP populations and nonsorted
epithelial cells was extracted and reverse-transcribed. qRT–PCR
was performed using platinum qPCR SuperMix-UDG and the
following TaqMan probes: Mm00501602_m1 (Igf2bp1) and
Mm02342456_g1 (Rsp6). Samples were run in duplicate, and expression was determined by a standard curve of pooled nonsorted
intestinal epithelial cells and normalized to the invariant control
gene Rps6.

Elements basic research software version 4.51. Imaging was performed at room temperature. The following primary antibodies
were used for immunostaining: anti-Ki67 (1:200), anti-lysozyme
(1:1000), anti-chromagranin A (1:1000), anti-H2AX (1:1000),
anti-IMP1 (1:1000), anti-AXIN2 (1:4000), and anti-β-catenin
(1:1000). Cy2- or Cy3-conjugated secondary antibodies were
obtained from Jackson Immunoresearch Laboratories, Inc. Biotinylated secondary antibodies and the DAB substrate kit for immunohistochemistry were purchased from Vector Laboratories.
All quantifications were done across at least 30 high-powered
fields per animal that were randomly selected areas throughout
the small intestine of at least four mice in each genotype. For
quantifying regeneration after irradiation, regenerative microcolonies/foci were defined as a cluster of five or more Ki67-positive
cells from a single clone (colony or hyperproliferative crypt).

Flow cytometry and sorting

For analysis of EdU-positive cells, the mice were injected with
20 mg/kg EdU intraperotoneally. The mice were sacrificed 2 h
after the injection. The single-cell suspensions of crypt-enriched
intestinal epithelium from the small intestine (jejunum) of the
mice were then stained for EdU following the manufacture’s
instructions. For sorting, mouse intestinal epithelial cells were
isolated into single cells. CD24-PE (Biolegend) and cKit PE-Cy7
(eBioscience) staining was done for sorting as per the manufacturer’s instructions. Flow cytometry was performed using a FACS
LSR (BD Biosciences) with a 100-µm nozzle. Sorting was done using a FACS Aria (BD Biosciences) sorter. Gating and compensation were performed using negative and single-color controls.
Three biological replicates (and three technical replicates) for
each genotype were used.

Quantification and statistical analysis

Statistical analysis was performed using Graphpad Prism software version 7.0. One-way ANOVA with Tukey’s post-hoc test
was performed to compare the differences among groups in all
studies. Unpaired t-test (two-tailed) was used when two groups
were compared. For all experiments with error bars, the standard
error of the mean (SEM) was calculated, and the data are presented
as mean ± SEM. The sample size for each experiment is included
in the figure legends.

Data and software availability

See “Ribosome profiling data processing and analysis” for software information. The accession numbers for all new RNA-seq
data and ribosome-profiling data reported here have been deposited in Gene Expression Omnibus (accession no. GSE115647).
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